Comparison of three arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet aggregation

Journal of Veterinary Pharmacology and Therapeutics

Volumn 27, Issue 5, 2004, Pages 377-379

  Weiss, Douglas J ^a,b   Evanson, O A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; ARGINYLGLYCYLASPARTIC ACID; COLLAGEN; DRUG METABOLITE; EPTIFIBATIDE; FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCYLPROLYLARGINYLPROLINE; HEXAPEPTIDE; INDOMETACIN; N ETHYL N [4 (4 PIPERIDINYL)BUTYRYL]GLYCYLASPARTYL 3 CYCLOHEXYLALANINAMIDE; PARACETAMOL; PEPTIDE DERIVATIVE; PHENYLBUTAZONE; PROSTAGLANDIN SYNTHASE INHIBITOR; RPR 109035; RPR 110885; THROMBIN; THROMBOXANE A2; TIROFIBAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; HORSE; IC 50; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT;

ANIMALS; ARGININE; ASPARTIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCINE; HORSES; PEPTIDES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 8344278751     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00592.x     Document Type: Article

References (14)

1. Alexander, J.H. & Harrington, R.A. (1998) Recent antiplatelet drug trials in the acute coronary syndromes - clinical interpretation of Prism, Prism-plus, Paragon A and Pursuit. Drug, 56, 965-976.
2. Bednar, B., Cummingham, M.E., Mcqueney, P.A., Egbertson, M.S., Askew, B.C., Bednar, R.A., Hartman, G.D. & Gould, R.J. (1997) Flow cytometric measurement of kinetic and equilibrium binding parameters of arginine-glycine-aspartatic acid ligands in binding to glycoprotein IIb/IIIa on platelets. Cytometry, 28, 58-65.
3. Cambridge, H., Lees, P., Hooke, R.E. & Russell, C.S. (1991) Anti-thrombotic actions of aspirin in the horse. Equine Veterinary Journal, 23, 123-127.
4. Cannon, C., McCabe, C.H. & Borzak, S. (1997) Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Circulation, 97, 340-349.
5. Cook, N.S., Kotirsch, G. & Zerwes, H.G. (1994) Platelet glycoprotein IIb-IIIa antagonists. Drugs Future. 19, 135-159.
6. Dyke, C.M. (1999) Safety of glycoprotein IIb-IIIa inhibitors: a heart surgeon's perspective. American Heart Journal, 138, S307-S316.
7. Foster, R.H. & Wiseman, L.R. (1998) ABCIXIMAB - a review of its use in ischemic heart disease. Drugs, 56, 629-665.
8. Gulba, D.C., Huber, K., Moll, S. & Dietz, R. (1998) Platelet inhibition - new agents, new strategies, new trails. Fibrinolysis Proteolysis, 12, 13-23.
9. Heath, M.F., Evans, R.J., Poole, A.W., Hayes, L.J., McEvoy, R.J. & Littler, R.M. (1994) The effects of aspirin and paracetamol on the aggregation of equine blood platelets. Journal of Veterinary Pharmacology and Therapeutics, 17, 374-378.
10. Meyers, K.M., Lindner, B.S., Katz, J. & Grant, B. (1979) Phenylbutazone inhibition of equine platelet function. American Journal of Veterinary Research, 40, 265-270.
11. Samanem, J., Ali, F., Romoff, T. et al. (1991) Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. Journal of Medicinal Chemistry, 34, 3114-3125.
12. Weiss, D.J., Evanson, O.A. & Wells, R.E. (1997) Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function. American Journal of Veterinary Research, 58, 457-460.
13. Weiss, D.J., Evanson, O.A., McClenahan, D., Fagliari, J.J., Dunnwiddi, C.T. & Wells, R.E. (1998) Effects of a competitive inhibitor of platelet aggregation on experimentally induced laminitis in ponies. American Journal of Veterinary Research, 59, 814-817.
14. Weiss, D.J., McCullough, C.B. & Mursky, M. (2000) Treatment of dogs with arginine-glycine-aspartate-containing peptide induces decreased platelet survival and deposition of platelets in the spleen. Toxicologic Pathology, 28, 310-316.